feed,title,long_url,short_url
SeekingAlpha,Biogen's gene therapy fails to meet phase 2/3 eye disease main goal,https://seekingalpha.com/news/3696529,
SeekingAlpha,SNC Lavalin reports Q1 results,https://seekingalpha.com/news/3696528,
